Stay updated on First-Line Tarlatamab Combo in ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The locations section has been expanded to list more trial sites across the US, Canada, Australia, Europe, and Asia, organized by region. This makes it easier for potential participants to find a nearby site and assess eligibility.
    Difference
    1%
    Check dated 2025-12-23T09:55:19.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Non-substantive metadata updates were made: a general note about voluntary publication submissions was added (2025-11-25), the 'Last Update Posted (Estimated)' field was updated (2025-11-20), and an earlier PubMed-based publication note and prior 'Last Update Posted' entry were removed (September 2024).
    Difference
    0.2%
    Check dated 2025-12-01T19:31:24.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The Publications section was updated to clarify that PubMed items are auto-filled and to specify the page revision numbers (v3.3.2 vs v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T16:48:31.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Location entry changed from Tainan City, Taiwan, 70403 to Tainan, Taiwan, 70403; the government funding lapse notice banner was removed.
    Difference
    0.3%
    Check dated 2025-11-17T15:00:15.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The differences are minor UI and formatting adjustments to the Study Details page without changes to core study data such as eligibility criteria, primary outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:32:51.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Minor metadata update: the citation’s online-ahead-of-print note and date formatting were adjusted; core study information remains the same.
    Difference
    0.6%
    Check dated 2025-10-19T16:36:12.000Z thumbnail image

Stay in the know with updates to First-Line Tarlatamab Combo in ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.